E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/30/2023 in the Prospect News Structured Products Daily.

New Issue: Citigroup prices $750,000 9% securities linked to Truist, Abbott, Union Pacific

By Angela McDaniels

Tacoma, Wash., May 30 – Citigroup Global Markets Holdings Inc. priced $750,000 of 9% equity-linked securities due Jan. 11, 2024 linked to the worst performing of the common stocks of Truist Financial Corp., Abbott Laboratories and Union Pacific Corp., according to a 424B2 filing with the Securities and Exchange Commission.

Interest is payable monthly.

The payout at maturity will be par unless the worst-performing stock finishes below its downside threshold, 50% of its initial share price, in which case investors will be exposed to the decline of the worst-performing stock.

The notes are guaranteed by Citigroup Inc.

Citigroup Global Markets Inc. is the underwriter.

Issuer:Citigroup Global Markets Holdings Inc.
Guarantor:Citigroup Inc.
Issue:Equity-linked securities
Underlying stocks:Truist Financial Corp., Abbott Laboratories and Union Pacific Corp.
Amount:$750,000
Maturity:Jan. 11, 2024
Coupon:9%, payable monthly
Price:Par
Payout at maturity:Par unless worst-performing stock finishes below downside threshold, in which case exposure to decline of worst-performing stock
Initial share prices:$48.01 for Truist, $109.49 for Abbott and $212.63 for Union Pacific
Downside thresholds:$24.005 for Truist, $54.745 for Abbott and $106.315 for Union Pacific, or 50% of initial share prices
Strike date:July 7, 2022
Pricing date:July 8, 2022
Settlement date:July 13, 2022
Underwriter:Citigroup Global Markets Inc.
Fees:0.3%
Cusip:17330PSM2

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.